Vidal-GutiŽrrez
X, G—mez-Clavel JF, Gait‡n-Cepeda LA. Dental
extraction following zoledronate, induces
osteonecrosis in rat«s jaw.
Med
Oral Patol Oral Cir Bucal. 2017 Mar 1;22 (2):e177-84.
doi:10.4317/medoral.21609
http://dx.doi.org/doi:10.4317/medoral.21609
|
1.
Campisi G, Fedele S, Fusco V, Pizzo G, Di Fede O, Bedogni A. Epidemiology,
clinical manifestations, risk reduction and treatment strategies of jaw
osteonecrosis in cancer patients exposed to antiresorptive agents. Future
Oncol. 2014;10:257-75. |
|
|
|
|
|
2.
Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, et al.
Potential pathophysiological mechanism in osteonecrosis of the jaw. Ann N Y
Acad Sci. 2011;1218:62-79. |
|
|
|
|
|
3.
Berti-Couto SA, Vasconcelos AC, Iglesias JE, Figueiredo MA, Salum FG,
Cherubini K. Diabetes mellitus and corticotherapy as risk factors for
alendronate-related osteonecrosis of the jaws: a study in wistar rats. Head
Neck. 2014;36:84-93. |
|
|
|
|
|
4.
Coskun Benlidayi I, Guzel R. Oral bisphosphonate related osteonecrosis of the
jaw: a challenging adverse effect. ISRN Rheumatol. 2013;2013:215034. |
|
|
|
|
|
5.
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws
associated with the use of bisphosphonates: a review of 63 cases. J Oral
Maxillofac Surg. 2004;62:527-34. |
|
|
|
|
|
6.
Colella G, Campisi G, Fusco V. American Association of Oral and Maxillofacial
Surgeons position paper: Bisphosphonate-related osteonecrosis of the
jaws-2009 update: the need to refine the BRONJ definition. J Oral Maxillofac
Surg. 2009;67:2698-9. |
|
|
|
|
|
7.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al.
American Association of Oral and Maxillofacial Surgeons. American Association
of oral and Maxillofacial Surgeons position paper on medication-related
osteonecrosis of the jaw-2014. J Oral Maxillofac Surg. 2014;72:1938-56. |
|
|
|
|
|
8.
Zhang X, Hamadeh IS, Song S, Katz J, Moreb JS, Langaee TY, et al. Osteonecrosis
of the jaw in the United States Food and Drug Administration's adverse event
reporting system (FAERS). J Bone Miner Res. 2016;31:336-40. |
|
|
|
|
|
9.
Pacheco VN, Langie R, Etges A, Ponzoni D, Puricelli E. Nitrogen-containing
bisphosphonate therapy: assessment of the alveolar bone structure in rats - a
blind randomized controlled trial. Int J Exp Pathol. 2015;96:255-60. |
|
|
|
|
|
10.
Hamadeh IS, Ngwa BA, Gong Y. Drug induced osteonecrosis of the jaw. Cancer
Treat Rev. 2015;41:455-64. |
|
|
|
|
|
11.
Kozloff KM, Volakis LI, Marini JC, Caird MS. Near-infrared fluorescent probe
traces bisphosphonate delivery and retention in vivo. J Bone Miner Res.
2010;25:1748-58. |
|
|
|
|
|
12.
Ali-Erdem M, Burak-Cankaya A, Cemil-Isler S, Demircan S, Soluk M, Kasapoglu
C, et al. Extraction socket healing in rats treated with bisphosphonate:
animal model for bisphosphonate related osteonecrosis of jaws in multiple
myeloma patients. Med Oral Patol Oral Cir Bucal. 2011;16:e879-83. |
|
|
|
|
|
13.
Biasotto M, Chiandussi S, Zacchigna S, Moimas S, Dore F, Pozzato G, et al. A
novel animal model to study non- spontaneous bisphosphonate necrosis of jaw.
J Oral Pathol Med. 2010;39:390-6. |
|
|
|
|
|
14. Bi
Y, Gao Y, Ehirchiou D, Cao C, Kikuiri T, Le A, et al. Biphosphonate cause
osteonecrosis of the jaw-like disease in mice. Am J Pathol. 2010;177:280-90. |
|
|
|
|
|
15.
Bonnet N, Lesclous P, Saffar JL, Ferrari S. Zoledronate effects on systemic
and jaw osteopenias in ovariectomized periostin-deficient mice. PLoS One.
2013;8:e58726. |
|
|
|
|
|
16. de
Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, et al.
Spontaneous osteonecrosis of the jaws in the maxilla of mice on
antiresorptive treatment: a novel ONJ mouse model. Bone. 2014;68:11-9. |
|
|
|
|
|
17.
Pautke C, Kreutzer K, Weitz J, Knšdler M, MŸnzel D, Wexel G, et al.
Biphosphonate related osteonecrosis of the jaw: A minipig large animal model.
Bone. 2012;51:592-9. |
|
|
|
|
|
18.
Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, et al.
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in
the rat. J Bone Miner Res. 2011;26:1871-82. |
|
|
|
|
|
19.
Aguirre JI, Altman MK, Vanegas SM, Franz SE, Bassit ACF, Wronski TJ. Effects
of alendronate on bone healing after tooth extraction in rats. Oral Dis.
2010;16:674-85. |
|
|
|
|
|
20.
Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the
jaws of rats treated with zoledronic acid and dexamethasone before dental
extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Oral Oncol. 2009;45:164-72. |
|
|
|
|
|
21.
Aghaloo TL, Cheong S, Bezouglaia O, Kostenuik P, Atti E, Dry SM, et al. RANKL
inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J
Bone Miner Res. 2014;29:843-54. |
|
|
|
|
|
22.
L—pez-Jornet P, Camacho-Alonso F, Molina-Mi-ano F, G—mez-Garc’a F,
Vicente-Ortega V. An experimental study of bisphosphonate-induced jaws
osteonecrosis in Sprague–Dawley rats. J Oral Pathol Med. 2010;39:697-702. |
|
|
|
|
|
23.
Jang HW, Kim JW, Cha IH. Development of animal model for
Bisphosphonates-related osteonecrosis of the jaw (BRONJ). Maxillofac Plast
Reconstr Surg. 2015;37:18. |
|
|
|
|
|
24.
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CYC. Severely
Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy. J
Clin Endocrinol Metab. 2005;90:1294-301. |
|
|
|
|
|
25.
Burr DB, Allen MR. Mandibular necrosis in beagle dogs treated with
bisphosphonates. Orthod Craniofac Res. 2009;12:221-8. |
|
|
|
|